CTRI/2023/10/059161CompletedNot Applicable
Effect of multi-component intervention on medication adherence among non-adherent type 2 diabetic patients in an urban area of South India. A cluster randomized control trial.
Saveetha medical College1 site in 1 country124 target enrollmentStarted: June 11, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 124
- Locations
- 1
- Primary Endpoint
- Blood glucose level (mg/dl)
Study Overview
Brief Summary
Diabetes is one of the most significant health problem and the most common chronic metabolic disease in the world and it is expected to be the 7th leading cause of death worldwide by 2030. There are only few interventional studies related to medication non adherence among type 2 Diabetes Mellitus patient in south India, hence this study has been done to evaluate the effectiveness of multicomponent intervention on medication non adherence in type 2 Diabetes Mellitus.
I will sent for publication once the trial is completed
Study Design
- Study Type
- Interventional
- Allocation
- Coin toss, Lottery, toss of dice, shuffling cards etc
- Masking
- Participant Blinded
Eligibility Criteria
- Ages
- 18.00 Year(s) to 80.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Adult individuals with Type 2 Diabetes mellitus over 18 years of age.
- •Old and newly diagnosed Type 2 diabetic patients.
- •Patients who were found to be non-adherent by MAQ scores of 1-4 presenting to the study setting for further management will be included in the study.
Exclusion Criteria
- •Person not willing to participate in the study.
- •Pregnant, lactating and trying to become pregnant.
- •Malignancy or life-threatening diseases.
Outcomes
Primary Outcomes
Blood glucose level (mg/dl)
Time Frame: 6months
Secondary Outcomes
- Blood glucose level (mg/dl)(0 and 3rd month of study)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Not yet recruiting
Phase 2
Novel Chinese Medicine Formula for DiabetesType 2 DiabetesNCT06978023Chinese University of Hong Kong162
Recruiting
Phase 4
Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and SafetyDiabetes Type 2NCT05915949Seoul National University Bundang Hospital99
Active, not recruiting
Not Applicable
Effect of a Pharmacist-led, Collaborative Practice on Clinical Outcomes in Persons with DiabetesType2diabetesDiabetesNCT05995262Methodist Health System100
Recruiting
Phase 2
Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT06010992Tanta University70
Recruiting
Unknown
Comparative study of efficacy, safety and patient compliance of Dapagliflozin(anti diabetic drug) and Metformin(anti diabetic drug) Vs Vildagliptin(anti diabetic drug) and Metformin combination therapy in newly diagnosed Type 2 diabetes patientsType 2 diabetes mellitus without complications,CTRI/2020/12/030147Kumar Gautam180